Test Code GLIADIGA GliadinDP IgA
Additional Codes
Meditech Order: GLIADINIGA
Panel Order:GLIADINABPNL
Intended Use
GliadinDP IgA is intended for the in vitro semi-quantitative measurement of IgA antibodies directed to gliadin in human serum or plasma (EDTA, Li- heparin) to aid in the diagnosis of celiac disease in conjunction with other laboratory and clinical findings. EliA GliadinDP IgA uses the EliA IgA method on the Phadia 250 instrument.
Performing Lab
Boone Health Laboratory
Collection Method
Venous Collection
Container
Gold Serum Tube
Instructions/Special Handling
None
Preferred Specimen
Gold SST Serum Tube
Red Serum
Acceptable Specimes
- Plasma
- Lithium Heparin
- EDTA
Units
| EliA U/mL |
Reference Ranges
| <7 | Negative |
| >10 | Positive |
| 7-10 | Equivoval (recommend retesting after 8-12 weeks) |
| >142 | >142 EliA U/mL |
Critical Values
N/A
Reasons for Rejection
| Hemolysis | >494 mg/dL |
| Icterus | >19.1mg/dL |
| Lipemia | >1000mg/dL |
| Other | QNS, Improperly labeled, Improper specimen type, Rheumatoid Factor IgM >550IU/mL and contaminated specimens. |
Specimen Stability
| Ambient (15-25°C) | 8 hours |
| Refrigerated (2-8°C) | 14 days |
| Frozen (-20°C) | 12months (only one freeze thaw cycle) |
Performance Information
| Days/Times Performed | Monday, Wednesday and Friday |
| Expected Turn around Time | 1-3 days |
| Methodology/Method Description | EliA IgA |
CPT Code(s)
86258